Egr-1 is a Major Vascular Pathogenic Transcription Factor in Atherosclerosis and Restenosis

Author： Blaschke Florian Bruemmer Dennis Law Ronald E.

ISSN： 1389-9155

Source： Reviews in Endocrine and Metabolic Disorders, Vol.5, Iss.3, 2004-08, pp. : 249-254

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Age-related changes in the signaling and function of vascular smooth muscle cells - soil for atherosclerosis and restenosis

By Lundberg M.S. Crow M.T.

Experimental Gerontology, Vol. 34, Iss. 4, 1999-08 ,pp. : 549-557

Elsevier

Access to resources Recommend Favorite

Association of Polymorphism in the Transcription Factor LBP-1c/CP2/LSF Gene with Alzheimer’s Disease and Major Depression

Dementia and Geriatric Cognitive Disorders, Vol. 22, Iss. 1, 2006-06 ,pp. : 95-98

Karger

Access to resources Recommend Favorite

Vascular progenitor cells and atherosclerosis

By Adams Benjamin Xiao Qingzhong Xu Qingbo

Future Cardiology, Vol. 3, Iss. 6, 2007-11 ,pp. : 635-645

Future Medicine

Access to resources Recommend Favorite

Relations between Plasma von Willebrand Factor or Endothelin-1 and Restenosis following Carotid Artery Stenting

Medical Principles and Practice, Vol. 21, Iss. 6, 2012-05 ,pp. : 538-542

Karger

Access to resources Recommend Favorite

The Molecular Mechanisms of Vascular Restenosis: Which Genes are Crucial?

Current Vascular Pharmacology, Vol. 4, Iss. 3, 2006-07 ,pp. : 269-275

Bentham Science Publishers

Access to resources Recommend Favorite